Robert E. Gagnon - 22 Jan 2026 Form 4 Insider Report for Opus Genetics, Inc. (IRD)

Role: Chief Financial Officer
Signature: /s/ Amy Rabourn, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 22 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 26 Jan 2026, 19:45:07 UTC
Previous filing: 18 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Gagnon Robert E.	Chief Financial Officer	C/O OPUS GENETICS, INC., 8 DAVIS DRIVE, SUITE 220, DURHAM	/s/ Amy Rabourn, by Power of Attorney	26 Jan 2026	0001504983

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRD	Common Stock	Award	$0	+400,000	+200%	$0.000000	600,000	22 Jan 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in substantially equal quarterly installments on the anniversary of the grant date over the next sixteen (16) quarters, subject to the Reporting Person's continuing service.